The transcriptional activity of ERα in breast tumor cells has been the subject of an impressive number of research papers in the last decades, especially because it represents one of the prototypes of druggable molecules in cancer, testified by the success of Tamoxifen and other antiestrogens in BC treatment since 1975 [12]. This evidence concerns the gene ESR1 and cancer.